Dr. Sonja Scholz, a senior investigator at NIH and adjunct professor at Johns Hopkins, shares her expertise in neurodegenerative dementias. She discusses the complex relationship between genetics and these diseases, emphasizing the significance of genome-wide association studies and genetic testing. The conversation also dives into advancements in biomarkers for accurate diagnostics and the future of treatments like precision medicine. Scholz highlights the need for research on atypical dementias, drawing from her clinical experiences with Parkinson's disease.